Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Share:
Related VRX
Morgan Stanley Lifts Target On Valeant From $235 To $284
Stocks Hitting 52-Week Highs
5 Top Stocks Riding Earnings Season To Big Gains (Investor's Business Daily)
Related AGN
Morgan Stanley Resumes Teva At Overweight, Sees Large EPS Growth Coming
5 Stocks With Notable Short-Selling Activity
IBD 50: 10 Top Stocks Reporting Earnings This Week (Investor's Business Daily)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

Get Benzinga's Newsletters